T1	Participants 75 102	recurrent gastric carcinoma
T2	Participants 369 430	a group of patients with recurrent gastric cancer was studied
T3	Participants 482 722	1) Intradermal group (ID Group), 42 patients given an intradermal injections of OK-432. 2) Intramuscular group (IM Group), 40 patients given an intramuscular injections of OK-432. 3) Control group (C Group), 39 patients not given injections
